Achelios Therapeutics Inc is a biopharmaceutical company based in Chapel Hill, NC, specializing in the development of topically delivered medications for the treatment of pain and inflammation. Their innovative technology allows for the successful transfer of non-steroidal anti-inflammatory drugs (NSAIDs) through the skin and into the target tissue, providing localized relief to patients suffering from chronic joint pain and other indications.
The company's primary focus is on their most advanced product, TOPOFEN, which is designed to treat chronic temporomandibular joint disorder (TMJD). With their patented therapies and commitment to improving the lives of patients, Achelios Therapeutics is at the forefront of developing novel therapies for pain management.
Generated from the website